Growth ahead for Japan's pharma, medtech

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2014

Singapore: Japan's pharmaceutical market was estimated to be worth $89.1 billion in 2012 and is expected to reach approximately $104.5 billion by 2020 at a compound annual growth rate (CAGR...Read more

Evolva, Ajinomoto enter development deal

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2013

Singapore: Evolva Holding SA entered into a collaboration agreement with Ajinomoto, Japan, for the joint development of novel fermentation production routes for a natural functional ingredi...Read more

Astellas, Sanwa launch hyperkalemia treatment

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jan, 2013

Singapore: Tokyo-headquartered Astellas Pharma and Sanwa Kagaku Kenkyusho, based in Nagoya, Japan, have launched a hyperkalemia treatment Argamate 89.29 percent Granule 5.6g in Japan. Arga...Read more

Sanofi seeks approval for Lyxumia in Japan

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

Singapore: Sanofi has submitted the marketing authorization application for Lyxumia, (lixisenatide), an investigational once-daily GLP-1 receptor agonist, to the Ministry of Health, Labour ...Read more

Hitachi mRNA assay to target personalized medicine

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Nov, 2012

Singapore: Hitachi Chemical has developed a novel mRNA quantitative assay called Hem(A)+ System that offers a wide range of applications in clinical biomarker discovery and molecular testi...Read more

Eisai to launch breast cancer drug in India

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Nov, 2013

Singapore: With an agenda to expand its footprint in the emerging markets, Japan's Eisai Pharma is launching its novel anti-cancer drug Eribulin, sold under the brand name of Halaven in Ind...Read more

Japan approves broader indication for Lyrica

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Mar, 2013

Singapore: Pfizer Japan has received approval in Japan to replace the current indication of peripheral neuropathic pain for pain treatment Lyrica Capsules (pregabalin) with the new and broa...Read more

Rienso gets marketing authorization in Europe

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2012

Singapore: Takeda Pharmaceutical and AMAG Pharmaceuticals have been granted marketing authorization by the European Commission for ferumoxytol, a new intravenous (IV) iron therapy to treat ...Read more

Consumers are winners in the BRCA gene case

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2013

In the wake of US Supreme Court's win-win verdict in Association for Molecular Pathology vs Myriad Genetics case, Frost and Sullivan life sciences industry analysts, Mr Justin Collishaw and...Read more

Otsuka, Lundbeck sign $825 mn Alzheimer's deal

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 27 Mar, 2013

Singapore: Denmark-based Lundbeck and Japanese company Otsuka Pharmaceutical have signed a license and development agreement for Lu AE58054, a selective 5HT6 receptor antagonist currently i...Read more

Takeda drug gets FDA nod for new biologic therapy

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2014

Singapore: Takeda Pharmaceutical has recieved Food and Drug Administration (FDA) approval for a new biologic therapy, Entyvio (vedolizumab), for the treatment of adults with moderately to s...Read more

PGA, Astellas conduct women's day at golf tour

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 28 Feb, 2013

Singapore: The PGA Tour and subsidiary of Tokyo-based Astellas Pharma launched its first 'Astellas Presents Executive Women's Day', a day-long forum focusing on professional, health-related...Read more

Daiichi Sankyo recruits patients for cancer trial

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2012

Singapore: US-based ArQule and Japanese Daiichi Sankyo have completed the recruitment of patients for their randomized, double-blind, controlled phase III MARQUEE pivotal trial of their inv...Read more

World's largest PK/PD group launches service in Asia

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Apr, 2013

Singapore: Certara, leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through clinical development, welcomed M...Read more

Chugai gives cancer drug license to Debiopharm

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

Singapore: Chugai Pharmaceutical and Debiopharm Group entered into a licensing agreement regarding FF284 (called Debio 1347 by Debiopharm), which was discovered by Chugai and is about to e...Read more

ASKLEP joins Medidata partner program

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Partner Program as part of its strategy to expand its existing offerings ...Read more

Bayer gets Japan's nod for gastro tumor drug

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Bayer has received Japan's approval for Stivarga indicated for the treatment of patients suffering from gastrointestinal stromal tumor (GIST) who have progressed following prior ...Read more

Noven Pharma files NDA with US FDA

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2012

Singapore: Noven Pharmaceuticals, a wholly-owned subsidiary of Japanese firm Hisamitsu Pharmaceutical, has submitted a new drug application (NDA) to the US Food & Drug Administration se...Read more